 Joaquin Espinosa
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 18 | 2023 | 338 | 5.100 |
Why?
| | Tumor Suppressor Protein p53 | 14 | 2023 | 447 | 3.600 |
Why?
| | Transcription, Genetic | 11 | 2021 | 1316 | 2.180 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 111 | 2.080 |
Why?
| | Transcriptional Activation | 6 | 2023 | 337 | 1.700 |
Why?
| | Neoplasms | 9 | 2023 | 2105 | 1.610 |
Why?
| | Proteome | 3 | 2022 | 339 | 1.330 |
Why?
| | Interferons | 4 | 2023 | 151 | 1.310 |
Why?
| | Transcriptome | 2 | 2022 | 727 | 1.070 |
Why?
| | Gene Regulatory Networks | 2 | 2021 | 228 | 1.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2021 | 1147 | 0.900 |
Why?
| | Receptors, Interferon | 2 | 2023 | 47 | 0.880 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 14 | 0.850 |
Why?
| | Transcription Factors | 8 | 2023 | 1528 | 0.790 |
Why?
| | Janus Kinase Inhibitors | 1 | 2021 | 10 | 0.780 |
Why?
| | Blood | 1 | 2022 | 96 | 0.770 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 16 | 0.770 |
Why?
| | Cell Death | 1 | 2022 | 322 | 0.750 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 77 | 0.730 |
Why?
| | Pyrimidines | 2 | 2021 | 378 | 0.720 |
Why?
| | Oncogenes | 1 | 2021 | 107 | 0.710 |
Why?
| | Kynurenine | 2 | 2023 | 80 | 0.700 |
Why?
| | Databases, Genetic | 1 | 2021 | 206 | 0.700 |
Why?
| | Piperidines | 1 | 2021 | 161 | 0.700 |
Why?
| | Trisomy | 2 | 2019 | 68 | 0.680 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2019 | 31 | 0.670 |
Why?
| | Apoptosis | 10 | 2023 | 2369 | 0.670 |
Why?
| | Interferon-alpha | 2 | 2020 | 187 | 0.660 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 282 | 0.640 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 152 | 0.640 |
Why?
| | Cyclin-Dependent Kinase 8 | 6 | 2022 | 38 | 0.630 |
Why?
| | Metabolome | 1 | 2021 | 283 | 0.620 |
Why?
| | Antineoplastic Agents | 4 | 2023 | 1895 | 0.560 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 665 | 0.550 |
Why?
| | Genomics | 1 | 2021 | 639 | 0.530 |
Why?
| | Humans | 51 | 2023 | 114756 | 0.510 |
Why?
| | Cell Line, Tumor | 9 | 2023 | 2725 | 0.500 |
Why?
| | Cell Proliferation | 6 | 2023 | 2196 | 0.490 |
Why?
| | Hypoxia | 1 | 2021 | 957 | 0.480 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 56 | 0.480 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 584 | 0.440 |
Why?
| | Datasets as Topic | 2 | 2022 | 98 | 0.380 |
Why?
| | RNA Polymerase II | 4 | 2019 | 285 | 0.370 |
Why?
| | Animals | 17 | 2023 | 31761 | 0.370 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2019 | 158 | 0.370 |
Why?
| | Mice | 13 | 2023 | 14916 | 0.360 |
Why?
| | Mediator Complex | 3 | 2022 | 52 | 0.320 |
Why?
| | Proteomics | 3 | 2023 | 843 | 0.310 |
Why?
| | Proto-Oncogene Proteins | 2 | 2023 | 610 | 0.280 |
Why?
| | Signal Transduction | 7 | 2023 | 4521 | 0.270 |
Why?
| | Case-Control Studies | 3 | 2023 | 3005 | 0.270 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2006 | 22 | 0.260 |
Why?
| | Cell Cycle | 2 | 2008 | 543 | 0.260 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2321 | 0.260 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2199 | 0.260 |
Why?
| | Metabolomics | 2 | 2021 | 527 | 0.260 |
Why?
| | Phosphorylation | 4 | 2022 | 1571 | 0.250 |
Why?
| | Cytokines | 4 | 2020 | 1843 | 0.240 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 249 | 0.240 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 15 | 0.230 |
Why?
| | Cyclins | 2 | 2022 | 78 | 0.230 |
Why?
| | Alzheimer Disease | 2 | 2020 | 443 | 0.220 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 463 | 0.220 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.220 |
Why?
| | Cell Cycle Proteins | 3 | 2023 | 552 | 0.220 |
Why?
| | Glutamine | 1 | 2023 | 91 | 0.220 |
Why?
| | Cell Line | 4 | 2019 | 2639 | 0.220 |
Why?
| | Protein Binding | 4 | 2021 | 1896 | 0.210 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2009 | 107 | 0.210 |
Why?
| | Cyclin C | 1 | 2022 | 2 | 0.210 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 23 | 0.210 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 79 | 0.210 |
Why?
| | Growth Disorders | 1 | 2022 | 77 | 0.200 |
Why?
| | Centrosome | 2 | 2022 | 60 | 0.200 |
Why?
| | Biomarkers | 3 | 2023 | 3416 | 0.200 |
Why?
| | DNA-Binding Proteins | 3 | 2016 | 1314 | 0.200 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 130 | 0.200 |
Why?
| | Gene Silencing | 1 | 2023 | 172 | 0.200 |
Why?
| | Medulloblastoma | 1 | 2023 | 172 | 0.200 |
Why?
| | Doxorubicin | 3 | 2007 | 286 | 0.190 |
Why?
| | Hematopoiesis | 2 | 2021 | 172 | 0.190 |
Why?
| | Cilia | 2 | 2022 | 162 | 0.190 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.180 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 23 | 0.180 |
Why?
| | RNA, Messenger | 3 | 2021 | 2557 | 0.180 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 31 | 0.180 |
Why?
| | MicroRNAs | 2 | 2018 | 601 | 0.180 |
Why?
| | Models, Biological | 1 | 2008 | 1630 | 0.180 |
Why?
| | Flow Cytometry | 2 | 2019 | 1086 | 0.180 |
Why?
| | Azetidines | 1 | 2020 | 31 | 0.180 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 286 | 0.180 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 216 | 0.180 |
Why?
| | Up-Regulation | 2 | 2021 | 812 | 0.180 |
Why?
| | Nuclear Proteins | 3 | 2023 | 592 | 0.180 |
Why?
| | Data Mining | 1 | 2021 | 100 | 0.180 |
Why?
| | Connective Tissue Diseases | 1 | 2020 | 71 | 0.170 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.170 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 4710 | 0.170 |
Why?
| | Heart Diseases | 1 | 2023 | 330 | 0.170 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 19 | 0.170 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 44 | 0.170 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1521 | 0.170 |
Why?
| | Protein Domains | 2 | 2017 | 207 | 0.170 |
Why?
| | Coinfection | 1 | 2020 | 120 | 0.160 |
Why?
| | Genome, Human | 1 | 2021 | 351 | 0.160 |
Why?
| | Inflammation | 2 | 2020 | 2481 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.150 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 13 | 0.150 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 73 | 0.150 |
Why?
| | Inpatients | 1 | 2022 | 378 | 0.150 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 31 | 0.150 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 13 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 359 | 0.150 |
Why?
| | Stem Cell Niche | 1 | 2018 | 42 | 0.150 |
Why?
| | Calcinosis | 1 | 2020 | 242 | 0.150 |
Why?
| | Bacterial Infections | 1 | 2020 | 219 | 0.150 |
Why?
| | Promoter Regions, Genetic | 3 | 2013 | 1133 | 0.150 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 61 | 0.150 |
Why?
| | Female | 12 | 2021 | 59507 | 0.150 |
Why?
| | Cell Survival | 1 | 2021 | 1021 | 0.150 |
Why?
| | Autoimmunity | 1 | 2023 | 814 | 0.150 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1745 | 0.140 |
Why?
| | Adult | 5 | 2021 | 30548 | 0.140 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 171 | 0.140 |
Why?
| | Sulfonamides | 1 | 2020 | 445 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 795 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 254 | 0.140 |
Why?
| | Hedgehog Proteins | 1 | 2018 | 173 | 0.140 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.140 |
Why?
| | Antigens | 1 | 2018 | 318 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 863 | 0.140 |
Why?
| | Osteosarcoma | 1 | 2017 | 67 | 0.140 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.140 |
Why?
| | Exosomes | 1 | 2017 | 91 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 143 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2019 | 722 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2023 | 3542 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 221 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2023 | 1699 | 0.130 |
Why?
| | Autophagy | 1 | 2018 | 233 | 0.130 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 153 | 0.130 |
Why?
| | HCT116 Cells | 3 | 2019 | 71 | 0.130 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 70 | 0.130 |
Why?
| | Phenotype | 1 | 2023 | 2812 | 0.130 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 345 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 334 | 0.120 |
Why?
| | Bone Neoplasms | 1 | 2017 | 194 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 529 | 0.120 |
Why?
| | Fibroblasts | 1 | 2019 | 838 | 0.120 |
Why?
| | Azepines | 1 | 2015 | 74 | 0.120 |
Why?
| | Repressor Proteins | 1 | 2017 | 367 | 0.120 |
Why?
| | Gene Expression | 1 | 2019 | 1420 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2018 | 696 | 0.120 |
Why?
| | Disease Progression | 1 | 2021 | 2387 | 0.110 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2013 | 13 | 0.110 |
Why?
| | Middle Aged | 4 | 2021 | 26757 | 0.110 |
Why?
| | Mitogens | 1 | 2013 | 58 | 0.110 |
Why?
| | Down-Regulation | 1 | 2015 | 596 | 0.110 |
Why?
| | Binding Sites | 2 | 2014 | 1176 | 0.110 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 157 | 0.100 |
Why?
| | Feedback, Physiological | 1 | 2012 | 68 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1728 | 0.100 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 854 | 0.100 |
Why?
| | RNA Stability | 1 | 2012 | 90 | 0.100 |
Why?
| | Chromatin | 3 | 2016 | 428 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2097 | 0.090 |
Why?
| | Sirtuins | 1 | 2010 | 32 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 386 | 0.080 |
Why?
| | Male | 5 | 2021 | 55579 | 0.080 |
Why?
| | S Phase | 1 | 2009 | 70 | 0.080 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.080 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2008 | 20 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2008 | 787 | 0.080 |
Why?
| | Young Adult | 2 | 2021 | 10463 | 0.080 |
Why?
| | Hydroxyurea | 2 | 2023 | 30 | 0.080 |
Why?
| | RNA | 1 | 2014 | 810 | 0.080 |
Why?
| | Formaldehyde | 1 | 2007 | 46 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2008 | 140 | 0.070 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2007 | 44 | 0.070 |
Why?
| | Radiation, Ionizing | 1 | 2007 | 72 | 0.070 |
Why?
| | Protein Kinases | 1 | 2009 | 307 | 0.070 |
Why?
| | Acetylation | 1 | 2007 | 211 | 0.070 |
Why?
| | RNA Precursors | 1 | 2007 | 136 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1868 | 0.070 |
Why?
| | Fluorouracil | 1 | 2007 | 152 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2019 | 2582 | 0.070 |
Why?
| | Kinetics | 2 | 2007 | 1550 | 0.070 |
Why?
| | Transcription Factors, TFII | 1 | 2006 | 37 | 0.070 |
Why?
| | Transcription Factor TFIIH | 1 | 2006 | 34 | 0.060 |
Why?
| | Transcriptional Elongation Factors | 1 | 2006 | 32 | 0.060 |
Why?
| | High Mobility Group Proteins | 1 | 2006 | 49 | 0.060 |
Why?
| | Protein Transport | 1 | 2007 | 396 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2006 | 129 | 0.060 |
Why?
| | Serine | 1 | 2006 | 126 | 0.060 |
Why?
| | Glucose | 1 | 2010 | 897 | 0.060 |
Why?
| | Protein Isoforms | 1 | 2006 | 339 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 706 | 0.060 |
Why?
| | Hemoglobin, Sickle | 1 | 2023 | 14 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 928 | 0.060 |
Why?
| | Glutamates | 1 | 2023 | 58 | 0.060 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 18 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 40 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 797 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 46 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2023 | 34 | 0.050 |
Why?
| | Proline | 1 | 2023 | 72 | 0.050 |
Why?
| | L-Selectin | 1 | 2023 | 25 | 0.050 |
Why?
| | Perforin | 1 | 2023 | 19 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 134 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 215 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 42 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 147 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 146 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 172 | 0.050 |
Why?
| | Histones | 1 | 2007 | 536 | 0.050 |
Why?
| | Centrioles | 1 | 2022 | 35 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 145 | 0.050 |
Why?
| | Clonal Evolution | 1 | 2021 | 27 | 0.050 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 184 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2022 | 222 | 0.050 |
Why?
| | Genetic Testing | 1 | 2022 | 379 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 251 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2018 | 3890 | 0.040 |
Why?
| | Microtubules | 1 | 2022 | 237 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2020 | 130 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 9 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 166 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 128 | 0.040 |
Why?
| | HeLa Cells | 2 | 2013 | 562 | 0.040 |
Why?
| | Purines | 1 | 2020 | 159 | 0.040 |
Why?
| | Heart | 1 | 2023 | 609 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 65 | 0.040 |
Why?
| | DNA | 1 | 2006 | 1351 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2018 | 6 | 0.040 |
Why?
| | Child | 3 | 2023 | 18352 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 24 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 75 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 320 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2018 | 105 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 189 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 689 | 0.040 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 49 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 364 | 0.040 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 9 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 561 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2023 | 965 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 20 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 528 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 295 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1197 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 164 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 62 | 0.030 |
Why?
| | Imidazoles | 1 | 2017 | 211 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1151 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 95 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 368 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 372 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 723 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 52 | 0.030 |
Why?
| | Piperazines | 1 | 2017 | 311 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2017 | 285 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1642 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 867 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 15 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 811 | 0.030 |
Why?
| | Genes, ras | 1 | 2013 | 91 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2018 | 769 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 137 | 0.030 |
Why?
| | Liver | 1 | 2020 | 1631 | 0.030 |
Why?
| | Adolescent | 2 | 2023 | 17808 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1053 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2017 | 966 | 0.030 |
Why?
| | Chronic Disease | 1 | 2017 | 1590 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 593 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3334 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4420 | 0.020 |
Why?
| | Cell Respiration | 1 | 2010 | 75 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2010 | 42 | 0.020 |
Why?
| | Daunorubicin | 1 | 2009 | 24 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2009 | 21 | 0.020 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2009 | 17 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2009 | 28 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 63 | 0.020 |
Why?
| | Coenzymes | 1 | 2008 | 16 | 0.020 |
Why?
| | Caffeine | 1 | 2009 | 57 | 0.020 |
Why?
| | Glycolysis | 1 | 2010 | 227 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 14 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 354 | 0.020 |
Why?
| | RNA Caps | 1 | 2007 | 31 | 0.020 |
Why?
| | Genes, myc | 1 | 2007 | 47 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 205 | 0.020 |
Why?
| | Poly A | 1 | 2007 | 46 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 8627 | 0.020 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2007 | 23 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 271 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2008 | 633 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1233 | 0.020 |
Why?
| | Infant | 1 | 2017 | 7935 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 9079 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 448 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 3350 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1378 | 0.010 |
Why?
|
|
Espinosa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|